v3.25.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net income (loss) $ (1,587,132) $ 370,386
Reconciliation of net income (loss) to net cash used in operating activities    
Depreciation and amortization 127,440 89,135
Stock based compensation for services 754,256 443,811
Issuance of warrants for interest 24,477 9,947
Gain on extinguishment of debt (2,417,502)
Loss on disposal of assets 1,000
Changes in operating assets and liabilities    
Prepaid expenses (300) (31,239)
Accounts payable (49,371) (13,664)
Deferred wages and directors’ fees — related party 282,090 718,625
Interest payable - related party (9,219) 42,297
Right of use lease 5,067 (4,209)
Net cash used in operating activities (452,692) (791,412)
Cash flows from investing activities    
Net purchase of property and equipment (68,899)
Deposit on land (50,000)
Patent and trademark costs (8,262) (30,230)
Net cash used in investing activities (127,161) (30,230)
Cash flows from financing activities    
Proceeds from exercise of warrants 6,250
Proceeds from the issuance of notes payable - RP 185,000 680,000
Proceeds from the issuance of convertible notes - other 250,000
Proceeds from issuance of common stock and warrants 435,000
Net cash provided by financing activities 626,250 930,000
Net increase (decrease) in cash and cash equivalents 46,397 108,358
Cash and cash equivalents at beginning of the period 48,797 41,008
Cash and cash equivalents at end of the period 95,194 149,366
Non-cash Financing and Investing Activities    
Recognition of Operating lease liability and right-of-use asset 452,132
Issuance of common stock for patent and trademark costs 38,463
Issuance of common stock for property and equipment 67,253
Issuance of common stock and warrants on the conversion of notes payable $ 50,000 $ 225,000